FDA to carry out satisfaction survey on inspections
This article was originally published in Clinica
The FDA plans to conduct a random "customer satisfaction" survey over the next year to give medical device companies an opportunity to vent their frustrations anonymously about the US agency's inspection process.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.